IJCM  Vol.3 No.6 , November 2012
Cellular Profiles in Peripheral Blood Accompanying Particular Asthmatic Response Types
Author(s) Zdenek Pelikan*
ABSTRACT
Background: Patients with allergic bronchial asthma develop various asthmatic response types to bronchial challenge with allergen, such as immediate (IAR), late (LAR), dual late (DLAR) or delayed (DYAR), displaying different clinical, immunologic and pharmacologic features. This study deals with count changes of particular blood cells accompanying the IAR, LAR and DYAR. Methods: In 63 patients developing 22 IAR, 26 LAR and 15 DYAR, the repeated allergen challenges were supplemented with recording of blood cell counts, Th1/Th2 ratio, leukotrines B4 (LTB4) and C4 (LTC4), eosinophil cationic protein (ECP), myeloperoxidase (MPO), and histamine in blood, and intracellular IFN-γ and IL-4 in peripheral blood mononuclear cells. Results: The IAR was accompanied by increased eosinophil and basophil counts, increased serum concentrations of histamine, LTC4 and ECP, decreased Th1/Th2 ratio in favour of Th2 cells, and increased intracellular IL-4. The LAR was associated with increased eosinophil and neutrophil counts, increased serum concentrations of LTC4 and LTB4, unchanged Th1/Th2 ratio, and increased intra-cellular IL-4. The DYAR was accompanied by increased total leukocyte, neutrophil, monocyte, lymphocyte and thrombocyte counts, increased serum concentrations of LTB4 and MPO, increased Th1/Th2 ratio in favour of Th1 cells, and increased intracellular IFN-γ. Conclusions: These results provide evidence for different involvement of particular blood cell types and different hypersensitivity mechanisms in IAR, LAR and DYAR. The monitoring of peripheral blood cell counts seems to be an useful supplementary parameter to the bronchial challenge with allergen.

Cite this paper
Z. Pelikan, "Cellular Profiles in Peripheral Blood Accompanying Particular Asthmatic Response Types," International Journal of Clinical Medicine, Vol. 3 No. 6, 2012, pp. 485-497. doi: 10.4236/ijcm.2012.36088.
References
[1]   S. T. Holgate, R. F. Lemanske, P. M. O’Byrne, et al., “Asthma Pathogenesis,” In: N. F. Adkinson, B. S. Bochner, W. W. Busse, S. T. Holgate, R. F. Lemanske, F. E. Simons, Eds., Middleton’s Allergy, Principles & Practice (7th ed.). Elsevier Inc., Philadelphia, 2009, pp. 893-919. doi:10.1016/B978-0-323-05659-5.00051-6

[2]   A. M. Bentley, A. B. Kay and S.R. Durham, “Human Late Asthmatic Responses,” In: A. B. Kay, Ed., Allergy and Allergic Diseases, Blackwell Sci Ltd., Hoboken, 1997, pp. 1113-1129.

[3]   Z. Pelikan, M. Pelikan-Filipek, M. Kruis and M. P. F. Berger, “The Immediate Asthmatic Response to Allergen Challenge,” Ann Allergy, Vol. 56, 1986, pp. 252-260.

[4]   J. Douwes, P. Gibson, J. Pekkanen and N. Pearse, “Non-Eosinophilic Asthma: Importance and Possible Mechanisms,” Thorax, Vol. 57, No. 7, 2002, pp. 643-648. doi:10.1136/thorax.57.7.643

[5]   T. J. Huang, P. A. MacAry, P. Eynott, A. Mousavi, K. C. Daniel, P. W. Askenase, D. M. Kemeny and K. F. Chung, “Allergen-Specific Th1 Cells Counteract Efferent Th2 Cell-Dependent Bronchial Hyperresponsiveness and Eosinophilic Inflammation Partly via IFN-γ,”Journal of Immunology, Vol. 166, No. 1, 2001, pp. 207-217.

[6]   D. E. Shaw, M. A. Berry, B. Hargadon, et al., “Association between Neutrophilic Airway Inflammation and Airflow Limitation in Adults with Asthma,” Chest, Vol. 132, No. 6, 2007, pp. 1871-1875. doi:10.1378/chest.07-1047

[7]   P. Haldar and I. D. Pavord, “Noneosinophilic Asthma: A Distinct Clinical and Pathologic Phenotype,” Journal of Allergy and Clinical Immunology, Vol. 119, No. 5, 2007, pp. 1043-1052. doi:10.1016/j.jaci.2007.02.042

[8]   J. V. Fahy, “Eosinophilic and Neutrophilic Inflammation in Asthma,” Proceedings of the American Thoracic Society, Vol. 6, No. 3, 2009, pp. 256-259. doi:10.1513/pats.200808-087RM

[9]   M. Yoshida, R. M. Watson, T. Rerecich and P. M. O’Byrne, “Different Profiles of T-Cell IFN-γ and IL-12 in Allergen-Induced Early and Dual Responders with Asthma,” Journal of Allergy and Clinical Immunology, Vol. 115, No. 5, 2005, pp. 1004-1009. doi:10.1016/j.jaci.2005.02.003

[10]   A. J. Frew, J. St-Pierre and L. M. Teran, “Cellular and Mediator Responses Twenty-Four Hours after Local Endobronchial Allergen Challenge of Asthmatic Airways,” Journal of Allergy and Clinical Immunology, Vol. 98, No. 1, 1996, pp. 133-143. doi:10.1016/S0091-6749(96)70235-X

[11]   L. Bancalari, F. L. Dente, S. Cianchetti, C. Prontera, M. Taccola, E. Bacci, A. Carletti, A. Di Franco, D. Giannini, B. Vagaggini, M. Ferdeghiani and P. L. Paggiare, “Blood Markers of Early and Late Airway Responses to Allergen in Asthmatic Subjects. Relationship with Functional Findings,” Allergy, Vol. 52, No. 1, 1997, pp. 32-40. doi:10.1111/j.1398-9995.1997.tb02543.x

[12]   B. Pedersen, R. Dahl, B. B. Larsen and P. Venge, “The Effects of Salmeterol on the Early- and Late-Phase Reaction to Bronchial Allergen and Postallergen Variation in Bronchial Reactivity, Blood Eosinophils, Serum Eosinophil Cationic Protein, and Serum Eosinophil Protein X,” Allergy, Vol. 48, No. 5, 1993, pp. 377-382. doi:10.1111/j.1398-9995.1993.tb02410.x

[13]   Z. Pelikan and M. Pelikan-Filipek, “The Late Asthmatic Response to Allergen Challenge—Part I and II,” Annals of Allergy, Vol. 56, No. 5, 1986, pp. 414-420,421-435.

[14]   Z. Pelikan, “Delayed Type of Asthmatic Response to Allergen Challenge. I. Clinical Features,” Annals of Allergy, Asthma & Immunology, Vol. 104, No. 5, 2010, pp. 394-404. doi:10.1016/j.anai.2010.03.014

[15]   Z. Pelikan, “Delayed Asthmatic Response to Bronchial Challenge with Allergen and Mediators, Eicosanoids, Eosinophil and Neutrophil Constituents in Blood and Serum,” Respiration, Vol. 82, No. 3, 2011, pp. 225-236.

[16]   M. Pelikan-Filipek, Y. A. Trimbach, M. Van Oosten, S. Fouchier and Z. Pelikan, “The Changes in the Count of Particular Cell Types in Blood during the Immediate/ Early Asthmatic Response [IAR/EAR] Due to the Allergen Challenge,” Allergy, Vol. 51, Suppl. 31, 1996, p. 29.

[17]   Z. Pelikan and M. Pelikan-Filipek, “The Counts of Particular Cell Types and Their Changes in Blood Accompanying the Late Asthmatic Response [LAR] Due to the Allergen Challenge,” Allergy, Vol. 51, Suppl. 31, 1996, p. 118.

[18]   T. J. H. Clark, C. B. Cagnani, J. Bousquet, et al., “Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report,” NHI Publication No. 02-3659, Bethesda, Geneve, 2002.

[19]   G. Melillo, S. Bonini, G. Cocco, R. J. Davies, R. G. De Monchy, L. Frolund and Z. Pelikan, “Provocation Tests with Allergens,” Allergy, Vol. 52, Suppl. 35, 1997, pp. 5-36.

[20]   P. J. Sterk, L. M. Fabbri, P. H. Quanjer, D. W. Cockcroft, P. M. O’Byrne, S. D. Anderson, E. F. Juniper and J. L. Malo, “Airway Responsiveness. Standardized Challenge Testing with Pharmacological, Physical and Sensitizing Stimuli in Adults,” European Respiratory Journal, Vol. 16, 1993, pp. 53-83.

[21]   D. J. Houd and C. C. Taylor, “Multivariate Analysis of Variance and Repeated Measures,” Chapman & Hall, London, 1987.

[22]   S. Finotto, L. M. Fabbri, V. Rado, C. E. Mapp and P. Maestrelli, “Increase in Numbers of CD8 Positive Lymphocytes and Eosinophils in Peripheral Blood of Subjects with Late Asthmatic Reaction Induced by Toluene Diisocyanate,” British Journal of Industrial Medicine, Vol. 48, No. 2, 1991, pp. 116-121.

[23]   W. O. Cookson, C. F. Craddock, M. K. Benson and S. R. Durham, “Falls in Peripheral Eosinophil Counts Parallel the Late Asthmatic Response,” American Journal of Respiratory and Critical Care Medicine, Vol. 139, No. 2, 1989, pp. 458-462. doi:10.1164/ajrccm/139.2.458

[24]   W. J. Metzger, K. Nugent, H. B. Richerson, P. Moseley, R. Lakin and D. Zavala, “Methods for Bronchoalveolar Lavage in Asthmatic Patients Following Bronchoprovocation and Local Allergen Challenge,” Chest, Vol. 87, Suppl. 1, 1985, pp. 16S-19S. doi:10.1378/chest.87.1_Supplement.16S

[25]   R. Dahl, P. Venge and I. Olsson, “Variations of Blood Eosinophils and Eosinophil Cationic Protein in Serum in Patients with Bronchial Asthma,” Allergy, Vol. 33, No. 4, 1978, pp. 211-215. doi:10.1111/j.1398-9995.1978.tb01536.x

[26]   I. M. Ndukwu, E. T. Naureckas, C. Maxwell, M. Waldman and A. R. Leff, “Relationship of Cellular Transmigration and Airway Response after Allergen Challenge,” American Journal of Respiratory and Critical Care Medicine, Vol. 160, No. 5, 1999, pp. 1516-1524.

[27]   B. Asman, V. Strand, G. Bylin and K. Bergstrom, “Peripheral Neutrophils after Allergic Asthmatic Reaction,” International Journal of Clinical & Laboratory Research, Vol. 27, No. 2-4, 1997, pp. 185-188. doi:10.1007/BF02912455

[28]   T. Nabe, N. Shinoda, K. Yamashita, H. Yamamura and S. Kohno, “Leukocyte Kinesis in Blood, Bronchoalveoli and Nasal Cavities during Late Asthmatic Responses in Guinea-Pigs,” European Respiratory Journal, Vol. 11, No. 3, 1998, pp. 636-642.

[29]   C. Fornhem, M. Kumlin, J. M. Lundberg and K. Alving, “Allergen-Induced Late-Phase Airways Obstruction in the Pig: Mediator Release and Eosinophil Recruitment,” European Respiratory Journal, Vol. 8, No. 7, 1995, pp. 1100-1109. doi:10.1183/09031936.95.08071100

[30]   Q. Hamid, M. K. Tulic, M. C. Liu and R. Moqbel, “Inflammatory Cells in Asthma: Mechanisms and Implications for Therapy,” Journal of Allergy and Clinical Immunology, Vol. 111, No. 1, 2003, pp. S5-S17. doi:10.1067/mai.2003.22

[31]   B. M. Saraiva-Romanholo, V. Barnabe, A. L. Carvalho, M. A. Martins, P. H. Saldiva and P. Nunes Mdo, “Comparison of Three Methods for Differential Cell Count in Induced Sputum,” Chest, Vol. 124, No. 3, 2003, pp. 1060-1066. doi:10.1378/chest.124.3.1060

[32]   P. Maestrelli, M. Saetta, A. Di Stefano, P. G. Calcagni, G. Turato, M. P. Ruggieri, A. Roggeri, C. E. Mapp and L. M. Fabbri, “Comparison of Leukocyte Counts in Sputum, Bronchial Biopsies, and Bronchoalveolar Lavage,” American Journal of Respiratory and Critical Care Medicine, Vol. 152, No. 6, 1995, pp. 1926-1931.

[33]   L. W. Poulter, A. Norris, C. Power, A. Condez, B. Schmekel and C. Burke, “T-Cell Dominated Inflammatory Reactions in the Bronchi of Asthmatics Are Not Reflected in Matched Bronchoalveolar Lavage Specimens,” European Respiratory Journal, Vol. 5, 1992, pp. 182-18.

[34]   N. N. Jarjour, W. J. Calhoun, E. A. Kelly, G. J. Gleich, L. B. Schwartz and W. W. Busse, “The Immediate and Late Allergic Response to Segmental Bronchopulmonary Provocation in Asthma,” American Journal of Respiratory and Critical Care Medicine, Vol. 155, 1997, pp. 1515-1521.

[35]   R. P. Baughman, “Technical Aspects of Bronchoalveolar Lavage: Recommendations for a Standard Procedure,” Seminars in Respiratory and Critical Care Medicine, Vol. 28, No. 5, 2007, pp. 475-485. doi:10.1055/s-2007-991520

[36]   H. Imaoka, G. M. Gauvreau, R. M. Watson, T. Strinich, G. L. Obminski, K. Howie, K. J. Killian and P. M. O’Byrne, “Sputum Inflammatory Cells and Allergen-Induced Airway Responses in Allergic Asthmatic Subjects,” Allergy, Vol. 66, No. 8, 2011, pp. 1075-1080. doi:10.1111/j.1398-9995.2011.02588.x

[37]   Z. Pelikan, “Delayed Type of Asthmatic Response to Allergen Challenge and Cytokines in the Peripheral Blood,” Respiration, Vol. 84, No. 5, 2012, pp. 385-395. doi:10.1159/000335258

[38]   Z. Pelikan, “Chemokine Profiles in Blood Associated with Delayed Asthmatic Response to Allergen Challenge,” Respiratory Medicine, 2012. doi:10.1016/j.rmed.2012.09.013

 
 
Top